Larry Goldstein to Fibrinolytic Agents
This is a "connection" page, showing publications Larry Goldstein has written about Fibrinolytic Agents.
Connection Strength
3.592
-
Routine 24-Hour Computed Tomography Brain Scan is not useful in stable patients Post Intravenous Tissue Plasminogen Activator. J Stroke Cerebrovasc Dis. 2016 Mar; 25(3):540-2.
Score: 0.450
-
Temporal changes in the external validity of clinical trials: asymptomatic carotid artery stenosis. Cerebrovasc Dis. 2014; 38(3):174-5.
Score: 0.416
-
Modern medical management of acute ischemic stroke. Methodist Debakey Cardiovasc J. 2014 Apr-Jun; 10(2):99-104.
Score: 0.401
-
Poststroke pharmacotherapy: another ictus. Stroke. 2012 Dec; 43(12):3433-5.
Score: 0.364
-
Use of antithrombotic medications among elderly ischemic stroke patients. Circ Cardiovasc Qual Outcomes. 2011 Jan 01; 4(1):30-8.
Score: 0.318
-
Antithrombotic therapy for ischemic stroke: guidelines translated for the clinician. J Thromb Thrombolysis. 2010 Apr; 29(3):368-77.
Score: 0.304
-
Primum non nocere: antithombotics after intracerebral hemorrhage? Neurology. 2006 Jan 24; 66(2):162-3.
Score: 0.227
-
Association of Antithrombotic Drug Use With Incident Intracerebral Hemorrhage Location. Neurology. 2024 Jun 25; 102(12):e209442.
Score: 0.202
-
IV tPA for acute ischemic stroke: Times are changing. Neurology. 2016 11 22; 87(21):2178-2179.
Score: 0.120
-
Chronic kidney disease and stroke. Adv Chronic Kidney Dis. 2014 Nov; 21(6):500-8.
Score: 0.104
-
Author response. Neurology. 2014 Jan 07; 82(1):95.
Score: 0.099
-
Interventional and new approaches to stroke prevention: introduction. Stroke. 2013 Jun; 44(6 Suppl 1):S37.
Score: 0.095
-
Summary of evidence-based guideline: periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013 May 28; 80(22):2065-9.
Score: 0.094
-
Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012 Dec; 43(12):3442-53.
Score: 0.089
-
Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke. 2011 Sep; 42(9):2645-50.
Score: 0.084
-
Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Cerebrovasc Dis. 2009; 27(3):254-8.
Score: 0.070
-
Acute ischemic stroke treatment in 2007. Circulation. 2007 Sep 25; 116(13):1504-14.
Score: 0.064
-
Statewide assessment of hospital-based stroke prevention and treatment services in North Carolina: changes over the last 5 years. Stroke. 2003 Dec; 34(12):2945-50.
Score: 0.049
-
Guidelines on the use of thrombolytic agents in stroke. JAMA. 1995 Jul 19; 274(3):218.
Score: 0.027
-
Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003 Apr; 34(4):1056-83.
Score: 0.012
-
Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. Stroke. 1990 Sep; 21(9):1289-92.
Score: 0.005